About
UE LifeSciences (UELS) is a healthcare technology company dedicated to developing mobile health solutions for early cancer detection, particularly in underserved populations in low- and middle-income countries. The company aims to make cancer screening accessible and equitable, with a strong focus on women's health. UELS operates globally, with a presence in markets such as the United States, Malaysia, India, and various regions across Africa, South Asia, South-East Asia, the Middle East, and Latin America. The company collaborates with public and private healthcare providers to reach over a billion potential beneficiaries. Its flagship product, iBreastExam, is a painless, radiation-free breast health screening device that community health workers can easily operate. This device has been FDA cleared and CE marked, and it has screened over 75,000 women, leading to the diagnosis of more than 100 breast cancer cases. UELS also offers cervAIcal, a product focused on cervical cancer detection, further enhancing its portfolio in women's health screening technologies.
Technologies
Keywords
Company Information
-
Employees 61
-
Founded 2009
-
Annual Revenue $6000000
-
Total Funding $4760308
Location
3411 Market St, Philadelphia, Pennsylvania, United States, 19104
